Eli Lilly Says It Warned Doctors Of Cymbalta 'Brain Zaps'
Eli Lilly & Co. urged a California federal judge on Monday to toss a class action alleging inadequate labeling of its antidepressant Cymbalta, saying it sufficiently disclosed to doctors the risk...To view the full article, register now.
Already a subscriber? Click here to view full article